YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
YIHCF · OTC
12/31/2024 | 6/30/2024 | 12/31/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Market Cap | $3,532,490 | $3,517,732 | $3,449,164 | $3,509,405 |
| - Cash | $1,403,777 | $1,523,120 | $1,674,413 | $3,781,609 |
| + Debt | $2,234,835 | $2,339,292 | $2,609,328 | $4,479,669 |
| Enterprise Value | $4,363,548 | $4,333,904 | $4,384,079 | $4,207,465 |
| Revenue | $1,269,021 | $2,454,762 | $3,085,583 | $3,209,002 |
| % Growth | -48.3% | -20.4% | -3.8% | – |
| Gross Profit | $844,826 | $1,949,232 | $2,421,827 | $2,563,937 |
| % Margin | 66.6% | 79.4% | 78.5% | 79.9% |
| EBITDA | -$7,936,333 | $9,006,755 | $1,499,410 | $1,659,866 |
| % Margin | -625.4% | 366.9% | 48.6% | 51.7% |
| Net Income | -$202,019 | $684,731 | $963,129 | $1,029,495 |
| % Margin | -15.9% | 27.9% | 31.2% | 32.1% |
| EPS Diluted | -0.23 | 0.78 | 1.09 | 1.17 |
| % Growth | -129.5% | -28.4% | -6.8% | – |
| Operating Cash Flow | $65,013 | $24,405 | $428,413 | $1,244,799 |
| Capital Expenditures | -$780,211 | -$401,892 | -$128,132 | -$215,586 |
| Free Cash Flow | -$715,198 | -$377,487 | $300,281 | $1,029,213 |